• See how Pat responded hearing his voice for the first time here
  • See how Project Revoice gave Pat Quinn his voice back here
  • See how Project Revoice re-created Pat’s voice here

The new development will see an end to ‘Stephen Hawking-style’ machine voices, and enable all those with degenerative voice conditions to bank and use their natural voices, if they lose the ability to speak.

In mid 2018 Project Revoice will be launching a facility for people to record their voices via the website, so they can be digitally recreated in the future.

To demonstrate the power of this innovation, Project Revoice has given Pat Quinn, co-founder of the ALS Ice Bucket Challenge, his voice back. Pat did not record (or voice bank) his voice before ALS/Motor Neurone Disease robbed him of his ability to speak, but using footage from his many Ice Bucket interviews, Project Revoice has been able to rebuild his voice. Watch how this Australian initiative rebuilt his voice here.

Project Revoice was developed by creative agency BWM Dentsu Group in Australia, alongside Canadian software partner Lyrebird. Project Revoice uses state-of-the-art deep learning algorithms to create artificial voices that sound more natural than ever possible before. With only two-to-three hours of high-quality audio recordings, this model can synthesise the essence of a voice and build a complete digital recreation. By linking this tech to eye reader assistive technology, Pat Quinn can now deliver words in his own original voice.

Pat Quinn says: “This takes speech tech to a whole new level and means everything to how I communicate. I really didn’t like to hear my old computer voice, so I often avoided getting involved in conversations. This technology gives me back a vital piece of myself that was missing. After hearing my voice through this new technology, I was blown away! For patients to know that they can still speak in their own voice after ALS [Motor Neurone Disease] takes it away will transform the way people live with this disease.”


“We first starting working on the idea of using advanced voice technology over a year ago. Voice tech is most commonly used for commercial purposes, so we really wanted to find a way to use this emerging tech in a more rewarding way.” comments Alex Carr, Managing Director, BWM Dentsu Group.

“This technology is 100% dependent on having consistent, high-quality voice material to work with. Since MND is a progressive and sometimes unpredictable disease, we believe it’s crucial to get the message out now and encourage more people to start thinking about voice banking while they still can, so they have the voice material necessary to create their ‘Revoice’ when the full application launches. ”

Lyrebird explains: “We have created a model which is able to identify what it is that makes your voice unique. We call this the DNA of your voice. Essentailly our model asks ‘how can I differentiate your voice from the other voices?’. It analyses the recordings comes up with the characteristics that make a voice unique and is able to generate phrases based on that.”

“Recreating Pat’s voice and hearing him use it for the first time with his friends and family was truly inspirational,” said Brian Frederick, Executive Vice President for Communications at The ALS Association. “The man who helped give ALS a voice now has his own voice back.”

Users can find out how to record and preserve their voices and sign up for updates on Project Revoice at #ProjectRevoice

To hear how your re-voiced voice might sound, you can check a lower-quality demo version at

For information and support regarding Motor Neurone Disease please contact MND Australia or on national freecall tel 1800 777 175.

For further content please click here:


Project Revoice was developed by creative agency BWM Dentsu Group in Australia. The Project Revoice team collaborated with Lyrebird in Canada, Finch and Rumble Studios in Sydney and the ALS Association in the USA to bring this revolutionary speech synthesis project to life.

Motor Nuerone Dieases (known as ALS in the US) is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. It effects the body’s ability to walk, move, eat, talk and breathe. Many people with ALS/MND lose the ability to speak and rely on a robotic “machine” voice to read the words they input into text-to-speech devices.

Daniel Williams, Haystac

Dani McComber, Haystac

Sarah Littlefair

61 (0)423 794 401

61 (0)458 338 134

61 (0)434 440 881

[email protected]

[email protected]

[email protected]

/Public Release. This material from the originating organization/author(s) may be of a point-in-time nature, edited for clarity, style and length. The views and opinions expressed are those of the author(s).